$78.74 +2.16 (%) Incyte Corp - NASDAQ

Jun. 29, 2016 | 04:00 PM

Headlines

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Partner Headlines

  1. Mid-Day Market Update: Dow Drops Over 300 Points; Cisco Shares Surge Following Strong Q2 Results

    Benzinga | Feb. 11, 2016 | 12:38PM EST
  2. Incyte Plummets After Stopping Trial Of Jakafi In Pancreatic Cancer

    IBD | Feb. 11, 2016 | 11:16AM EST
  3. Mid-Morning Market Update: Markets Open Lower; PepsiCo Posts In-Line Q4 Profit

    Benzinga | Feb. 11, 2016 | 09:48AM EST
  4. CTI-Baxalta Drug Withdrawn, Removing Potential Incyte Rival

    IBD | Feb. 10, 2016 | 13:50PM EST
  5. Mid-Afternoon Market Update: Dow Rises Over 100 Points; eBay Shares Drop On Disappointing Outlook

    Benzinga | Jan. 28, 2016 | 14:31PM EST
  6. Mid-Day Market Update: Facebook Surges On Strong Results; ServiceNow Shares Slip

    Benzinga | Jan. 28, 2016 | 12:00PM EST
  7. Mid-Morning Market Update: Markets Open Higher; Ford Tops Q4 Views

    Benzinga | Jan. 28, 2016 | 10:06AM EST
  8. Last-Hour Rally Erases Midday Losses As Indexes Close Mixed

    IBD | Jan. 19, 2016 | 16:49PM EST
  9. Benzinga's Top Initiations

    Benzinga | Jan. 5, 2016 | 09:54AM EST
  10. The 5 Top-Performing Big-Cap Drug Stocks Of 2015

    IBD | Dec. 30, 2015 | 14:16PM EST
  11. Incyte Announces Two Phase 3 Studies Show Sustained Benefits of Jakafi in Patients with Myeloproliferative Neoplasms (MPNs)

    Benzinga | Dec. 5, 2015 | 10:22AM EST
  12. Incyte Announces Phase 3 RESPONSE-2 Study of Jakafi Meets Primary Endpoint

    Benzinga | Dec. 5, 2015 | 10:20AM EST
  13. 3 Big Pharma Upgrades (And One Downgrade) At Barclays

    IBD | Dec. 1, 2015 | 15:31PM EST
  14. Goldman Sachs' Top 4 Smid-Cap Biotech Picks

    IBD | Nov. 18, 2015 | 15:36PM EST
  15. Lilly, Incyte Announce Data Demonstrate Baricitinib Superiority to Adalimumab in Improving Signs and Symptoms of RA

    Benzinga | Nov. 7, 2015 | 20:04PM EST
  16. The Best-Performing Stocks Among Vanguard Health Care Fund's Holdings

    GuruFocus | Nov. 4, 2015 | 15:42PM EST
  17. Lilly and Incyte Announce Webcast to Discuss Baricitinib Phase 3 Data

    Benzinga | Oct. 27, 2015 | 13:20PM EST
  18. Amazon Among Ken Fisher's Best Performing Stocks

    GuruFocus | Oct. 19, 2015 | 19:18PM EST
  19. Lilly-Incyte drug beats Humira

    IBD | Oct. 14, 2015 | 18:35PM EST
  20. Lilly-Incyte Drug Beats Humira In Arthritis Trial

    IBD | Oct. 14, 2015 | 11:12AM EST
  21. Incyte and Merck Expand Clinical Collaboration to Include Phase 3 Study Investigating the Combination of Epacadostat with Keytruda® (pembrolizumab) as First-line Treatment for Advanced Melanoma

    Benzinga | Oct. 13, 2015 | 07:30AM EST
  22. Lilly Upgraded On Bullish Diabetes Outlook

    IBD | Oct. 9, 2015 | 12:11PM EST
  23. AbbVie Spurns Galapagos To Advance Own Arthritis Drug

    IBD | Sep. 25, 2015 | 12:51PM EST
  24. Amgen And Biogen Lead Short Interest Surge In Biotechs

    Benzinga | Sep. 14, 2015 | 16:01PM EST
  25. Incyte Announces Global License Agreement with Jiangsu Hengrui Medicine for SHR-1210

    Benzinga | Sep. 2, 2015 | 05:01AM EST
  26. Benzinga's Top Initiations

    Benzinga | Aug. 13, 2015 | 09:31AM EST
  27. What Will Gilead Buy Next? 4 Possible Targets

    IBD | Jul. 15, 2015 | 16:44PM EST
  28. Celgene Hits High As Street Applauds Receptos Buyout

    IBD | Jul. 15, 2015 | 11:12AM EST
  29. Immunovaccine Collaborates With Incyte to Evaluate Novel Immunotherapy Combination for Patients With Platinum-Sensitive Ovarian Cancer

    Benzinga | Jun. 25, 2015 | 07:07AM EST
  30. Benzinga's Top Initiations

    Benzinga | May. 29, 2015 | 09:25AM EST
  31. Lilly and Incyte Announce Webcast to Discuss Baricitinib Phase III Data

    Benzinga | May. 28, 2015 | 13:00PM EST
  32. It's A Big Weekend For Biotech

    Benzinga | Apr. 17, 2015 | 16:31PM EST
  33. Incyte Describes Emerging Development Pipeline Related to Eleven Abstracts at AACR

    Benzinga | Apr. 17, 2015 | 07:39AM EST
  34. Morning Market Gainers

    Benzinga | Feb. 11, 2015 | 09:48AM EST
  35. 10 Biotech Stories You Might've Missed This Week

    Benzinga | Jan. 15, 2015 | 13:18PM EST
  36. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 1

    Benzinga | Jan. 12, 2015 | 08:55AM EST
  37. 3 Biotech ETFs Rally On Merger News

    Benzinga | Dec. 8, 2014 | 17:43PM EST
  38. 5 Stock-Moving Medtech Events This December

    IBD | Nov. 28, 2014 | 14:18PM EST
  39. Incyte Building Blockbuster Drug One Disease At A Time

    IBD | Nov. 17, 2014 | 15:58PM EST
  40. 1 Biotech Beast Worth Tracking

    Benzinga | Nov. 12, 2014 | 12:08PM EST
  41. Bank Of America Q3 Small & Mid-Cap Biotech Preview

    Benzinga | Oct. 20, 2014 | 16:58PM EST
  42. UPDATE: Incyte Partners With Genetech to Help With Trials

    Benzinga | Jul. 30, 2014 | 08:43AM EST
  43. Weekly CFO Sells Highlight: Aramark, Incyte Corp Ltd., Facebook Inc.

    GuruFocus | Jun. 9, 2014 | 12:16PM EST
  44. Weekly Insider Sells Highlight: ARMK, INCY, ESC, HUN

    GuruFocus | Jun. 8, 2014 | 18:27PM EST
  45. Surges In Biotech Short Interest (INCY, PCYC, RGEN)

    Benzinga | May. 11, 2014 | 16:35PM EST
  46. Mid-Day Losers Mar. 7, 2014: PXLW, ALOG, ALSK, NMRX, NLNK, EMAN

    Benzinga | Mar. 7, 2014 | 11:34AM EST
  47. Morning Movers for Mar. 7, 2014: SKUL, DLIA, BIG, GTAT, CCRN, FL Moving Higher; NLNK, FEYE, SWY, FCEL Lower

    Benzinga | Mar. 7, 2014 | 09:04AM EST
  48. US Stock Futures Edge Higher; All Eyes On Jobs Report

    Benzinga | Mar. 7, 2014 | 07:37AM EST
  49. UPDATE: Bank of America Reinstates Coverage on Incyte on Two Oncology Platforms

    Benzinga | Feb. 26, 2014 | 08:19AM EST
  50. BioMarin Bucks Biotech Short Interest Trend (BIIB, BMRN, MDVN)

    Benzinga | Feb. 13, 2014 | 10:18AM EST
Trading Center